Skip to content
Home
Visit our other Journals
About
Supporter
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
Visit
Specialties
Hematology
Oncology
Musculoskeletal Disorder
Rare Disease
Metabolic Disorder
Cardiovascular Disease
Ophthalmology
Neurology
Infectious Disease
View all Specialties
Technologies
Cell Therapy
MSC
iPSC
Gene Therapy
Genome Editing
Extracellular Vesicles
CAR-T Therapy
TCR Therapy
Tissue-Engineering & Biomaterials
View all Technologies
Topics
Treatment
Immuno-Oncology
Trial Updates
Perspectives
Manufacturing
COVID-19
View all Topics
Conferences
ASH 2022
TCT 2022
Meeting on the Med 2022
ICLE 2022
Advanced Therapies Week 2022
TERMIS 2021
ESGCT 2021
Meeting on the Mesa 2021
Advanced Therapies 2021
View all Conferences
About
Supporter
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
safety
2:08
Results from a Phase I trial of rapidly manufactured Prgn-3006 Ultracar-T in R/R AML
David Sallman
• 11 Dec 2022
2:45
Phase I study of CC-98633 in R/R multiple myeloma
Luciano Costa
• 11 Dec 2022
2:24
CAR T-cell therapy for neuroblastoma
Shigeki Yagyu
• 8 Apr 2022
1:54
Overexpression of the LBTR gene to optimize T cell proliferation
Mateusz Legut
• 31 Mar 2022
4:51
Challenges in manufacturing viral vectors for the clinic
Nathalie Clement
• 27 Jan 2022
1:58
Treating Krabbe disease with FBX-101
John Maslowski
• 27 Jan 2022
1:57
MOMENTUM: ARU-1801 in sickle cell disease
Will Chou
• 26 Jan 2022
3:09
Clinical translation of biomaterials
May Griffith
• 12 Nov 2021
4:31
The safety of AVR-RD-01 gene therapy for Fabry disease
Mark Thomas
• 29 Oct 2021
7:04
Applications of single-cell multi-omics analysis
Yan Zhang
• 21 Oct 2021
1:50
Utilizing single-cell multi-omics throughout the product pipeline
Yan Zhang
• 21 Nov 2021
2:17
Liquid vs solid tumor strategies in cell therapy
Kanya Rajangam
• 13 Oct 2021
2:26
Advantages of allogeneic NK cell therapy
Kanya Rajangam
• 13 Oct 2021
2:48
Developments in NK cell therapy
Kanya Rajangam
• 13 Oct 2021
0:59
Treating hematologic malignancies with immunotherapy
Kanya Rajangam
• 13 Oct 2021
1:05
NKX019 in B-cell malignancies
Kanya Rajangam
• 13 Oct 2021
1
2
Next
